TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.30$ +0.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 354 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UPB
Line item 2022 2023 2024 2025
18 117 482 354
18 117 479 352
17 26 326 102
17 110 470 342
0.4 0.2 1.2 0.7
125 240 12 14
4.9 6.5 11 13
0.1 0.0 0.7 0.7
0.7 2.0 4.0 2.7
-106 -123 470 340
-107 -128 -191 -334
36 36 51 54

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?